OnePlus has been making phones for some years now, and while it did stumble the past few years, the OnePlus 13 is one of its ...
Morning Overview on MSN
Galaxy S26 Ultra rumors hint it could reset the flagship standard
The early rumor mill around the Galaxy S26 Ultra is painting a picture of a device that could push Android flagships into a ...
Discover the Samsung Galaxy S26 Ultra with 60W fast charging, 1 UI 8 Beta, and enhanced file sharing. Launching February 2026 ...
BYD offered a first look at its new flagship electric SUV and sedan, claiming the new EVs redefine high-end standards. With over 480,000 new energy vehicles (NEVs) sold in November, BYD is coming off ...
As Samsung prepares for the next Galaxy Unpacked event in early 2026, those eager to see the Galaxy S26 Ultra are wondering ...
Alltrna, the preclinical Flagship Pioneering-backed biotech trying to turn transfer RNA (tRNA) into drugs, is slimming down as it works toward the clinic. The Massachusetts-based outfit has laid off ...
Samsung is one of the few smartphone companies possessing the ability to design its own high-end chipsets, along with Apple and HUAWEI (until the US trade ban nipped that in the bud). The Korean ...
Flagship Pioneering is boosting the clinical research capabilities of its biotech fleet with a new IQVIA collaboration. The CRO giant will provide Flagship’s companies with its artificial intelligence ...
Against a backdrop of rate cut expectations and persistent inflation, Eden Miner releases its Annual High-Yield Contract Series. Through strategic allocation, investors can build a five-figure USD ...
Faith Foushee is a CNET contributor and a former writer for SaveOnEnergy.com, covering energy-efficient products, renewables and other energy topics. She enjoys learning about new energy technology ...
Venture capital group Flagship Pioneering has raised $2.6 billion to support the development of around 25 startups operating in human health, sustainability, and artificial intelligence, with another ...
Flagship Pioneering, the investor behind Covid-19 vaccine maker Moderna, said today that it had raised $3.4 billion for a new fund. The fund is a giant one even at a time when investment has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback